flash
One in five physicians interested in iPad
The iPad is a completely new category for the industry and consumers.
Read the full storyTransparency Vs. Translucency in Reporting Physician Payments
“Transparency” is a word you often hear today. It’s being used a lot in relation to Wall Street bonuses. It’s also used by pharmaceutical companies who are reporting payments made to physicians.
The iPad future of medicine
The current Apple iPad has some shortcomings; you can’t multitask yet, it is costly, there is no FLASH and for the healthcare market there is no way to quickly enter data (i.e. via a stylus)
Read the full storyInital reaction from physicians on iPad: No thanks
“I can’t use it. Am I supposed to write with one finger while holding the iPad” said one family physician. “To cumbersome, it would have been a winner if it has a stylus and allowed me to write information on medical records or write an Rx” said another.
Read the full storyLexapro
For the core symptoms of Major Depressive Disorder (MDD) & Generalized Anxiety Disorder (GAD) in adults See the effect of Lexapro Proven efficacy in MDD and GAD FLASHNow FDA approved for MDD in adolescents aged 12 to 17 Click here to view the ad on AdPharm Brand name: Lexapro Generic name/category: Escitalopram, Selective serotonin reuptake inhibitors (SSRI) Company: Forest pharmaceuticals Country/Market: USA, North America Indication(s)/use: Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) Target: Healthcare Professionals (HCP) Medium: Print ad Size/duration: two-page Publication/Aired: Managed Healthcare Executive – August 2009 To see all of this brand’s ads on AdPharm, click here
Is Pharma Ready for the New iPhone (or any iPhone)?
In case you missed it (and welcome back to Earth if you did), Apple is releasing yet another version of the iPhone: the 3GS.
Read the full story









Business Week – Drug Marketing
Business Week – Pharma Marketing
Cafe Pharma
Clinical Trials.gov
FDA on Twitter
Pharma Live
Pharma Voice